Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)

BACKGROUND: Metastatic colorectal cancer (mCRC) with wild type expression of RAS and RAF genes can be treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, such as cetuximab, in combination with chemotherapy. Skin toxicity represents the most serious and frequent side effe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Oncol
Main Authors: De Luca, Rossella, Lo Coco, Gianluca, Addeo, Raffaele, Fattoruso, Silvia Ileana Sara, Auriemma, Annunziata, Paci, Roberta, Mistretta, Ornella, Epifanio, Maria Stella, Salvato, Angela, D’Agostino, Alberto, Cicero, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado: Elmer Press 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8297050/
https://ncbi.nlm.nih.gov/pubmed/34349854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1381
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares